Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of levosimendan in cardiac failure after heart valve surgery.

Trial Profile

Efficacy of levosimendan in cardiac failure after heart valve surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2009 Primary endpoint 'disease occurrence' has been met.
    • 29 Aug 2009 Results have been presented at ESC Congress 2009: Annual Congress of the European Society of Cardiology.
    • 20 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top